ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Dorsal Visual Stream in Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01378403
Recruitment Status : Completed
First Posted : June 22, 2011
Last Update Posted : June 22, 2011
Sponsor:
Information provided by:
Sheba Medical Center

Brief Summary:
Schizophrenia patients in comparing to normal controls show decreased ability to identify objects with decreased level of fragmentation, a task that is associated with magnocellular pathway function.

Condition or disease
Schizophrenia

Study Type : Observational
Actual Enrollment : 22 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Evaluation of Dorsal Visual Stream in Patients With Schizophrenia
Study Start Date : September 2007
Actual Primary Completion Date : July 2010
Actual Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients suffering from schizophrenia
Criteria

Inclusion Criteria:

  • Schizophrenia

Exclusion Criteria:

  • Ophthalomological or Neurological problems
  • Left handed

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01378403


Locations
Israel
Psychiatry Clinic - Sheba Medical Center
Ramat-Gan, Israel
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Revital Amiaz, MD Sheba Medical Center

Responsible Party: Revital Amiaz, MD - Senior Psychiatrist, Psychiatry clinic, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT01378403     History of Changes
Other Study ID Numbers: SHEBA-07-4545-RA-CTIL
First Posted: June 22, 2011    Key Record Dates
Last Update Posted: June 22, 2011
Last Verified: June 2011

Keywords provided by Sheba Medical Center:
Schizophrenia
Cognitive deficites
Degraded objects
Magnocellular pathway

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders